Clinical Oncology (2007) 19: 616e627doi:10.1016/j.clon.2007.06.002
Lifestyle During and After Cancer Treatment
*Bedford Hospital, Cranfield University & Addenbrooke’s Hospital Cambridge University NHS Trust, c/o The Primrose Unit,
Bedford Hospital, Bedford MK42 9DJ, UK; yCranfield Health, c/o Cranfield University, Wharley End, Cranfield MK43 0SU, UK
ABSTRACT:The aim of this overview was to examine the evidence for links between lifestyle during and after cancer treatment andquality of life, risk of treatment side-effects, rate of progression and prevention of relapse. The reviewed studies weredivided into categories according to the role lifestyle plays in progression, during treatment, and in relapse prevention. The evaluated evidence was utilised to show potential lifestyle interventions to facilitate well-being and quality-of-lifeinitiatives. There is now persuasive evidence that dietary choice and exercise can improve the physical andpsychological function of patients with cancer. There is also persuasive evidence that lifestyle choice can prevent canceror the reoccurrence of cancer in susceptible individuals, and possibly improve survival. Thomas, R., Davies N. (2007). Clinical Oncology 19, 616e627
ª 2007 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Key words: cancernet.co.uk, diet, exercise, lifestyle, progression, treatment
Historically, the link between cancer and lifestyle was
Nutritional deficiencies and malnutrition are associated with
highlighted by the increased incidence in Asian men and
poor tolerance and lower dose intensity and hence indirectly
women after migration to North America and Europe,
reduce therapeutic outcome The link between im-
implying environmental factors in addition to genetics alone
proved lifestyle and better disease response rates is more
Several cohort studies have subsequently confirmed the
difficult to prove, but emerging reliable data have been
risks of a stereotypical Western lifestyle, which include high
published evaluating patients with indolent or relapsing
fat and red meat consumption, a low intake of fresh
prostate cancer, where slow progression allows time for
vegetables and fruit, and low levels of exercise
alternative interventions These include a number of
Obesity could account for 14% of male and 20% of female
epidemiological and cohort studies, which have shown that
cancer deaths in the UK . A lack of physical activity is
dietary and lifestyle factors can mediate the transformation
particularly related to colorectal cancer and cohort studies
of latent prostate cancer into clinically apparent cancers
have shown a lower risk in the order of 40e50% compared with
and may influence this process . More convincingly,
those with a sedentary lifestyle The Harvard Center for
however, are two recent prospective studies that have
Cancer Control, for example, estimates that at least 15% of
generated copious media attention . The first in-
colon cancers could be prevented by 30 min daily exercise
volved a randomised study of 93 volunteers with early
Cynics may argue that lifestyle change after a diagnosis
prostate cancer from the USA who had opted not to undergo
of cancer is analogous to closing the stable door after the
conventional therapies. They were randomly assigned to
horse has bolted. On the contrary, emerging evidence
intensive nutritional counselling and lifestyle changes, or
shows that lifestyle can influence the rate of cancer
not, as part of their active surveillance. The lifestyle
progression, improve quality of life, reduce side-effects
changes in this study included a vegan diet supplemented
and risks during therapy, reduce the incidence of relapse,
with soy, vitamin E, fish oils, selenium and vitamin C,
and improve overall survival. Furthermore, there is in-
together with a moderate exercise programme and stress
creasing enthusiasm from patients to be involved in their
management techniques, such as yoga. Prostate-specific
own management decisions, which in practical terms often
antigen (PSA) levels decreased by 4% at 12 months in the
concerns diet and lifestyle activities . This paper reviews
intervention group, but increased by 6% in the control group;
published evidence for the benefits of an improved lifestyle
this was statistically significant (P ! 0.05). As a secondary
after a diagnosis of cancer and argues that as oncologists
end point, serum taken from patients from the intervention
we should be formally introducing lifestyle advice into
group and introduced to prostate cell lines in vitro was eight
times more likely to inhibit their growth than serum taken
ª 2007 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
LIFESTYLE DURING AND AFTER CANCER TREATMENT
from the control group (70% vs 6%, P ! 0.001). Furthermore,
of patients receiving radiotherapy, has been shown to
changes in PSA and cell line growth strongly correlated with
influence a patient’s nutritional state, increase morbidity,
and negatively affect chemotherapy dose intensity .
The second study, a prospective phase II study, evaluated
Regular light exercise has been shown to improve fatigue
48 men with PSA relapse after radiotherapy or prostatectomy,
and quality-of-life issues for patients with cancer, partic-
comparing PSA doubling time before and after the consump-
tion of about 200 ml pomegranate juice. There was a signif-icant prolongation of PSA doubling time from a mean of15 months at baseline to 54 months after treatment. As
a secondary end point, the patients’ baseline oxidative state
Thromboembolism remains a significant risk for patients with
was significantly lower at baseline and after pomegranate
malignancy, particularly those who are immobile, have under-
consumption, measured using three separate serum analyses
gone a recent surgery, or who are receiving or have previously
(serum induced proliferation and apoptosis of LNCaP cells,
received chemotherapy . Although strategies such as
serum lipid peroxidation and serum nitric oxide levels)
compression stockings, warfarin and low molecular weight
Other intervention strategies have focused on the cyclo-
heparin are essential, exercise remains a practical additional
oxygenase-2 (COX-2) pathway, which over-expresses in
aid in reducing this life-threatening complication .
about 75% of malignancies In humans, several retro-spective and prospective analyses have found an associationwith the use of non-steroidal anti-inflammatory drugs
(NSAIDs) and a lower incidence of prostate, bowel and breast
Body composition, particularly weight gain during and after
cancers . In the UK, a prospective study evaluated
adjuvant chemotherapy, is becoming an ever-increasing
dietary intervention supplemented by oral sodium salicy-
significant concern. Women with breast cancer, for exam-
lates for its COX properties and copper, manganese gluco-
ple, report a 45% incidence of significant weight gain, often
nates and vitamin C for their antioxidant effects Within
at a time in their lives that makes losing it difficult. The
this study, a small cohort of men with progressive early or
reasons are multifactorial, but whatever the cause, pro-
relapsing prostate cancer had stabilisation of PSA with
spective exercise intervention studies have shown signifi-
a mean duration of 17.2 months. It is not clear whether any
cant improvement in body fat and lean mass indices
one of the four components of the supplement was
. Likewise, exercise improves bone mineral density,
instrumental in this tumour stasis or whether the combina-
muscle strength and walking distance, all potential risk
tion was essential. Also, it is uncertain how much additional
benefit was derived from a controlled diet, as it has beenreported that people with diets rich in fruit and vegetables,particularly vegetarians, have serum salicylate equivalent to
a dose of 80 mg a day d more than enough to inhibit the COX
Mood status, depression and anxiety are commonly under-
pathway . Whether diet alone, salicylates alone, or
diagnosed in up to 50% of patients with cancer Cohort
a combination of both is the optimal approach remains
studies have suggested that depressed patients with lung
unanswered For this reason, a double-blind randomised
and breast cancer have reduced survival compared with
multicentre controlled trial is underway under the registra-
patients who are psychologically healthy . A number of
tion of the National Cancer Research Network (NCRN) using
prospective exercise intervention studies among patients
a combination of sodium salicylate, diet and supplements in
receiving therapies ranging from chemotherapy, radiother-
patients with indolent or relapsing prostate cancer. The
apy and hormone therapies have shown reduced levels of
primary end point, PSA kinetics, is powered to detect
depression, anxiety and improved quality of life .
a difference between both the control and intervention
In women with breast cancer, continuing exercise into the
arms, as well as all patients before and after trial entry
follow-up period has been shown to improve mood,happiness, self-esteem and energy .
Lifestyle Improving Well-being Duringand After Cancer Treatment
There is a wealth of information linking good nutritional
Constipation caused by immobility, opiate analgesics or
and exercise interventions with improved tolerability and
anti-emetics during chemotherapy remains a significant
quality of life during cancer therapy The most reliable
patient concern. Exercise increases bowel transit time and
data in this area have addressed the benefits of fatigue,
ameliorates constipation and its associated abdominal
thromboembolism, body composition, psychological well-
Fatigue, reported to be the most common side-effect in
Previously, data on associations between dietary factors
65e90% of patients receiving chemotherapy and in 80e90%
and survival from breast cancer have been derived from
follow-up and caseecontrol studies . The largest of
who continued to smoke it was 32 (confidence interval
these is the Nurse’s Health Study in which women with
12e69) A further study in patients with lung cancer
breast cancer completed a dietary questionnaire 1 year
showed that the chance of survival from the primary disease
after radical therapy. Women following their description of
was double if smoking ceased compared with 40% in patients
a prudent diet (high fruit, vegetable and fibre; low fat and
salt) had a statistically significant lower overall mortalityrate compared to those with a typical Western diet. Thespecific breast cancer mortality overall was not, however,
different, except in the comparison of the upper quartile of
Understanding the interaction between lifestyle and cancer
the prudent diet with the upper quartile of the Western
is complicated by the caveat that health-seeking enthusi-
diet and then only in a node-positive subgroup
asts often follow a range of behaviours from exercise to
A subgroup analysis of 4288 patients within the National
dietary manipulation, smoking cessation, reduction in body
Surgical Adjuvant Breast and Bowel Project (NSABP) trial
size, supplements and analgesic intake, confounding the
between 1989 and 1994 showed that very underweight
published data . Many of the underlying mecha-
(body mass index ! 19) and obese (body mass index O 35)
nisms of benefit or risk remain unproven, but emerging
colon cancer patients had worse overall survival than
evidence is suggesting an interesting causal relationship
normal weight patients. This was due to a greater risk of
cancer recurrence as well as non-cancer deaths Similar findings were shown in a retrospective analysis of1069 men with prostate cancer treated at the Cedars-Sinai
Medical Center Los Angeles between 1994 and 2002; obesemen had a higher risk of early disease recurrence
Antioxidants are thought to wield their anticancer properties
A cohort study of 526 cases of colorectal carcinoma
by directly or indirectly counterbalancing the superoxide
showed a 31% reduction in cancer deaths for the physically
free radicals produced from our diet or other environmental
active compared with the physically inactive across all stages
factors Although patients with established cancer
The benefit was greatest for stage II and III disease, with
have already sustained DNA damage in order to mutate from
a hazard ratio for colorectal cancer-specific survival of 0.49
benign to malignant cells, avoiding further DNA insult may
(adjusting for age, sex, and stage) in this subgroup. A similar
avoid further mutation of indolent malignant or pre-
finding was shown in the CALBG 89803 study in which 816
malignant cells into more aggressive phenotypes .
patients completed detailed lifestyle questionnaires during
Otherwise known as free radical scavengers, they are found
and after adjuvant chemotherapy for stage III colon cancer.
in a wide variety of dietary sources .
Increased physical activity was associated with improveddisease-free and overall survival. In practical terms, this
equated to a 35% improvement in disease-free survival forindividuals in the highest quintile of regular physical activity
Lycopene and beta-carotene are naturally occurring pig-
ments. As well as inducing antioxidant enzymes, there is
The most convincing data have been derived from a recent
growing evidence related to cell differentiation and pro-
prospective trial that randomised 2437 postmenopausal
liferation independent of this mechanism of action .
women with early breast cancer to receive nutritional and
Lycopene, predominant in tomatoes, has been shown to
lifestyle counselling, or not, as part of routine follow-up. The
have a protective benefit on prostate cancer risk among US
dietary intervention included eight biweekly individual
health professionals . For men with established cancer,
counselling sessions. Dietary fat intake reduction was
two small non-randomised studies looked at lycopene and
significantly greater in the dietary group. After 60 months
tomato sauce intake and showed decreased PSA progression
of follow-up, the breast cancer relapse rate was significantly
. Beta-carotene, found in carrots and green leafy
lower in the intervention group (P ¼ 0.03). This difference
vegetables, has also shown in vitro reduction of pro-
was even greater in the oestrogen receptor-negative sub-
liferation in prostate cancer cell lines . However, trials
group (P ¼ 0.018). There was a statistically significant
of supplemented beta-carotene in patients at high risk of
improvement in overall survival in the intervention arm,
lung cancer showed an elevated risk of lung and prostate
although this was only statistically significant for specific
cancer . Another large chemo-prevention study com-
breast cancer recurrence in oestrogen receptor-negative
bined beta-carotene with retinol and showed a lower risk of
prostate cancer in those with pre-intervention low plasma
Continuing to smoke after a diagnosis of cancer has been
levels of beta-carotene; those with high levels had a higher
shown to increase the risk of further neoplasms, increase
complications in surgery, radiation and chemotherapy,impair appetite and nutrition and reduce survival
In a retrospective study of 540 patients with histologicallyconfirmed small cell lung cancer, those who stopped smoking
Non-oestrogenic phytochemicals, or polyphenols, include
at the time of diagnosis had a relative risk of a second lung
the phenolic acids, namely benzoic acid (hydroxybenzoic
cancer of 11 (confidence interval 4.4e23), whereas, in those
acid, gallic acid) and cinnamic acid (caffeic and quinic acid),
LIFESTYLE DURING AND AFTER CANCER TREATMENT
together with the non-oestrogenic flavanoids, including
of prostate and breast cancer, but in these surveys a high
anthocyanidins, the flavanols (catechins and proanthocya-
dairy intake was associated with a high fat intake .
nidins), lignans and stilbens. These phytochemicals do not
Excessive dietary calcium reduces vitamin D, which has
act via a hormonal route, but have been shown to have some
shown anti-proliferative benefits that in theory are lost
direct antioxidative, anti-proliferative activities . Kaemp-
ferol, found in teas, broccoli and kale, has particularly beenshown to reduce the risk of ovary and breast cancer withinthe ongoing Nurses’ Health Study. These and other phyto-
chemicals are also commonly found in flaxseed, linseeds,
Phytoestrogens include flavones, isoflavones and flavanones,
nuts, cruciferous vegetables (e.g. cabbage, kale, broccoli),
which are derived in the human diet mainly from soy beans
prunes, brightly coloured vegetables, fruits and grains.
and legumes, including peas, lentils and beans Dietary
Antioxidants can be found in less obvious sources such as
intake could potentially create a more favourable hormonal
coffee and chocolate apples used for cider, and the
milieu for prostate cancer by inhibiting 5-alpha-reductase,
tannin component of red wine The Food and Drug
the enzyme responsible for converting testosterone to the
Administration has published league tables relating to
more active metabolite dihydrotestosterone . The
a food’s ability to induce these defence enzymes, known as
benefits or risks of phytoestrogenic supplements on breast
their oxygen radical absorbance capacity .
cancer remain controversial, although this issue may besolved by an ongoing national NCRN DietCompLfy study,
which is correlating the risks of breast cancer relapse withlevels of phytoestrogenic intake
Manganese, copper and zinc are dietary trace elements,classified as antioxidants because they are essential for theproduction of superoxide dismutase (SOD) and selenium is
essential for glutathione peroxidase . Together with
catalase these form enzymic defence against carcinogenicoxygen reduction metabolites It has been postulated
Vitamin A is a fat-soluble essential vitamin found in fish and
that intensive farming food techniques and food processing
dairy food in the preformed isoform retinol. It can also be
may reduce these trace metals in our diet . There is
ingested in fruits and vegetables that contain carotenoid
evidence of an increased risk of carcinogenesis in the
provitamins such as beta-carotene. Prostate cell line data
presence of copper, manganese or zinc deficiencies,
have shown increased apoptosis and reduced proliferation
particularly under conditions of high carcinogenic attack
when exposed to synthetic retinoids such as fenretinide
. Likewise, in genetically susceptible mice, fenretinide
in many food sources and tends to accumulate more in the
reduced the incidence of prostate cancer by 49% .
prostate. One in vitro study suggested that this may offer
However, in a subsequent prospective study involving 10
some protection against prostate cancer cell growth
472 US men, no reduction in prostate cancer incidence has
However, in the Health Professional Follow-up Study, men
yet been shown, although there have only been 93 events in
who took supplemental zinc of more than 100 mg/day or for
long durations were more than twice as likely to developadvanced prostate cancer compared with controls
Human prostate cell lines have shown growth inhibitionwith selenium. This double-blind trial evaluated the
Vitamin C has been shown to prevent the inhibition of gap-
benefits of dietary selenium. The primary end point, non-
junction intercellular communication (GJIC) induced by
melanoma skin cancer, was not statistically significantly
toxic products such as hydrogen peroxide. The inhibition of
reduced, but the incidence of prostate cancer was
GJIC is related to carcinogenesis and tumour promotion
significantly reduced . Several large ongoing prostate
. Vitamin C is involved in the mechanism that enables
prevention studies, including the SELECT study, are
DNA to ‘sense’ free radicals by integrating with the iron
imbedded in DNA, thereby facilitating DNA repair. It istherefore an important factor in immune surveillanceagainst cancer, as according to estimates, each cell in the
body can be expected to suffer about 100 000 DNA-
Four prospective cohort studies relating to calcium and
prostate cancer have been published Two studies witha mean calcium intake of between 1330 and 1840 mg/day
showed no associated risk. Two others, one involving 86 404men in the Cancer Prevention II (CPII) nutrition cohort,
Vitamin D is converted to the active metabolite calciferol in
with a mean intake of O2000 mg/day from food and
the kidney. Calciferol exposed to cancer cell lines reduces
supplements, showed a significantly higher risk of prostate
proliferation, promotes differentiation, inhibits invasion
cancer . Five of nine further questionnaire surveys
and loss of adhesion and promotes apoptosis
associated a high intake of dairy food with an increased risk
. It has also be shown to interact with the androgen
signalling pathway in vivo, inhibiting angiogenesis
a 63% reduction in prostate cancer, although this was not
Clinical studies of calcitriol can dangerously increase serum
calcium, but vitamin D analogues have been developed
Fat intake, of course, is not all bad; evidence from
without this risk and are being investigated in an ongoing
two large prospective studies and a smaller
caseecontrol study suggests a protective effect of oilyfish intake on cancer incidence and mortality . A unique
nutritional component of fish is the long-chain marineomega-3 fatty acids. Cell line xenografts and small human
Vitamin E in its eight naturally occurring tocopherol isoforms
studies have suggested that marine omega-3 fatty acids or
has been linked to a reduction in prostate cancer risk
the ratio of marine omega-3: omega-6 fatty acids can
The Alpha-Tocopherol Beta-Carotene Cancer Prevention
modulate the COX-2 pathway, a potential route for prostate
Study Trial (ATBC) involving 29 133 male smokers reported
a statistically significant reduction in prostate cancer in-cidence and mortality, although the primary end point oflung cancer was higher . In the Health Professional
Follow-up Study, vitamin E intake was also associated with
The over-expression of COX-2 correlates with a more
a decreased risk of prostate cancer in smokers, but not
aggressive phenotype and resistance to hormonal therapies.
overall . The serum-based CPII nutrition cohort study
In vitro, inhibitors of COX-2, such as NSAIDs, have been shown
showed an inverse correlation between plasma vitamin E
to induce apoptosis, inhibit proliferation, impair adhesion
levels and prostate cancer, again mainly among smokers and
and signal angiogenesis in prostate cancer cell lines and
mostly the gamma-tocopherol isoform mainly found in the
xenographs . Ongoing national studies are generally
diet rather than in over the counter supplements . In
concentrating on pure COX-2 inhibitors, which are thought to
a further trial involving 39 876 patients with diabetes or
avoid the unwanted gastrointestinal COX-1 effects while
cardiovascular disease, alpha-tocopherol showed no re-
amplifying the COX-2 effects. The benefits of salicylates in
duction in cancer, and the incidence of heart disease was
tablet form or those found naturally within the diet have not,
slightly worse Likewise, in the ATBC study, cerebral
however, been established and concerns have arisen with
haemorrhage risk was also higher in smokers with hyperten-
some pure COX-2 inhibitors. First, the reduction in gastroin-
sion who took alpha-tocopherol. The ongoing National
testinal side-effects of pure COX-2 inhibitors has not been as
Cancer Institute-sponsored double-blind randomised SELECT
strong as expected when tested clinically . Second,
study comparing selenium and vitamin E supplementation
prospective studies, including a COCHRANE meta-analysis,
against placebo will provide data on completion in 2013.
have shown a reduced incidence of malignancy associatedwith aspirin rather than other more selective NSAIDs
. Third, the only prospective randomised clinicalstudies in oncology published to date showing a protective
One probable mechanism of benefit for lifestyle changes
benefit against recurrent bowel cancer used aspirin .
during cancer relates to a reduction in body fat constitution:
Finally, the cardiac and renal safety of some third generation
associations of adiposity and outcome after cancer treat-
NSAIDs has more recently been put in doubt As
ment have been observed for colorectal cancer , but
mentioned above, people with diets rich in fruit and
also for breast and prostate cancer, with the
vegetables, particularly vegetarians, have serum salicylate
improvement in survival being a result of decreased cancer-
equivalent to a dose of 80 mg/day e more than enough to
and non-cancer-related weight loss The mechanism
initiate COX’s conversion of arachidonic acid to prostaglan-
of risk of being overweight for breast and endometrial cancer
dins . Also, these patients have a lower incidence of
may lie in their higher oestradiol levels, which have been
adverse gastrointestinal symptoms. A measure of COX-2
reported to reduce after weight reduction programmes
inhibition in further dietary intervention studies would be
Diet may also influence hormone production and metabolism
by a direct action and not via obesity . Animalresearch and caseecontrol studies have shown that diets
low in fat and high in fibre are associated with a highexcretion of oestrogen in the urine
Theories of the mechanisms of benefit include alterations
Statins, by chemically reducing fat absorption, may also
in prostaglandin levels/ratios and positive effects on the
have a preventive role over and above their ability to
immune system For colon cancer, exercise may
reduce cholesterol. Lovastatin and simvastatin have been
help by increasing the bowel transit time, reducing the
shown to trigger apoptosis in cancer cell lines Five
time that potentially carcinogenic substances are in
randomised trials have shown fewer colon and breast
contact with the bowel wall . Exercise and diet also
cancers and melanomas in long-term users of statins
help to control the body’s levels of serum lipids and
compared with controls The data for prostate cancer,
cholesterol; high levels have been particularly associated
however, are inconclusive, as two other large clinical
with a greater risk of advanced disease . However,
cohort studies did not show a reduced risk with statin
the most compelling emerging evidence lies in the idea
intake. A further cohort study of 16 976 subjects showed
that physical activity might exert its beneficial effect via
LIFESTYLE DURING AND AFTER CANCER TREATMENT
insulin-like growth factors (IGF) . A number of
between 1990 and 1994, in which they had previously
cohort studies have shown an increased risk of cancer,
shown a prognostic benefit of physical activity. This and
particularly colorectal, with higher levels of IGF-1 and
another large prospective cohort study from Melbourne,
C-peptide. An inverse relationship with insulin-like growth
Australia, reported statistically lower levels of IGF-1 and
factor binding protein 3 (IGFBP-3) levels has also
higher IGFBP-3 in those physically active before diagnosis
been shown, although this effect has not been confirmed in
and these collated with disease-specific survival and overall
all studies . The benefits of lowering IGF-1 may be
linked to its central role in growth regulation processes. The main stimulus for IGF-1 production comes from growth
hormone. This stimulatory effect of growth hormone ismodulated by insulin, which increases growth hormone
Dietary or inhaled chemicals, such as polycyclic aromatic
receptor levels and in turn IGF-1 . Early studies
hydrocarbons and aromatic amines, found in super-heated
have shown that after binding to its receptors, which are
processed or fried foods, are converted to products that
found on normal colonic mucosal cells as well as colon
can directly or indirectly oxidise water or oxygen into short-
cancer cells, IGF-1 can stimulate cell proliferation, inhibit
lived, but highly energetic, free radicals. These cause
apoptosis and promote angiogenesis . In the
double or single DNA strand breaks, allowing cancer-
circulation, as over 90% of IGF-1 is bound to IGFBP-3,
promoting genes to escape from the influence of their
binding inhibits the action of IGF-1 by limiting the
suppressor gene guardians . Numerous environmental
availability of free hormone. The most convincing clinical
studies have linked carcinogens to cancers and the USA
evidence comes from a cohort study of 41 528 people aged
Food and Drug Administration regularly publishes lists of
between 27 and 75 years with colorectal cancer, recruited
foods containing high levels of acrylamides and other
Table 1 e Tips to encourage healthy eating in cancer patients
Avoid processed fatty foods, cream, and fried foods. Check serum cholesterol and discuss taking astatin if elevated.
Use meat for its taste, preferably not more than once a day. Excess fat should be removed and themeat gently grilled rather than fried to further reduce the fat content and avoid burning. If extra oilneeds to be used in cooking, use olive oil rather than animal fat.
All fresh fish, but particularly the oily varieties such as mackerel and sardines. Fresh water fish suchas trout have the advantage of avoiding the potential heavy metal contamination of tuna and swordfish, which some suggest should not be eaten more than twice a week.
Try to avoid heavily processed foods, which often contain high concentrations of fat, salt, sugar and
food additives. Reducing the amount of time that vegetables are cooked should maintain the flavour. Wash salads and vegetables thoroughly to avoid pesticides and airborne chemicals, which may havesettled on them. Organic foods reduce the pesticide exposure further. Avoid excessive amounts offoods containing high levels of aromatic hydrocarbons and acrylamides, such as smoked food or thoseassociated with high temperature cooking processes such as deep fried foods, crisps, chips,barbecued, and heavily fried meats.
Brazil nuts, sardines, prawns; 60e75 mg/day; no more than 200 mg/day.
Unless prescribed for other reasons, avoid supplements that give more than 1500 mg of calcium and11 mg zinc per day.
Fresh fruit, raw and calciferous vegetables, grains, oily fish, nuts and salads. Unless you havediarrhoea, try to increase the amount of ripe fruit you eat each day, ideally by eating the whole fruit. Freshly squeezed fruit juices are recommended.
Onions, leeks, broccoli, blueberries, red wine, tea, apricots, pomegranates, chocolate, coffee,blueberries, kiwis, plums, cherries, ripe fruits, parsley, celery, tomatoes, mint, citrus fruit.
Soybeans and other legumes, including peas, lentils, pinto (baked beans) and other beans and nuts(supplements not recommended).
Skin of colourful foods such as cherries, strawberries, tannins (red wine), blackcurrant, blackberries,dates, cranberries, red grapes, white button mushrooms.
Flaxseed, linseeds, hemp nuts, grains.
Tomatoes, tomato sauce, chilli, carrots, green vegetables and dark green salads.
Table 2 e Summary of major lifestyle studies after cancer
Intensive dietary counselling or not.
serum fat levels and relapse-freesurvival.
Retrospective analysis of prospective studies
cancer in the low fat intake cohort.
very high BMI O 35 had worserecurrence rates and overallsurvival.
PSA, prostate-specific antigen; NSABP, National Surgical Adjuvant Breast and Bowel Project; BMI, body mass index.
potential carcinogens, such as pesticides, toxic additives
size, supplements and analgesic intake. Nevertheless,
and chemical contaminants . Avoiding carcinogens may,
despite these caveats there is now persuasive evidence
therefore, have a benefit in reducing the risk of developing
that a healthy lifestyle during and after cancer is associated
further cancers in patients who may be more susceptible
with improved physical and psychological well-being,
from a pre-existing genetic signature or damage from
reduced risks of treatment, enhanced self-esteem, reduced
chemotherapy or radiotherapy. The latter theory is sup-
risk of recurrence and improved survival. Prising the
ported by data from patients surviving the Hiroshima and
individual anticancer components of a healthy lifestyle will
Nagasaki bombings. A comprehensive medical follow-up of
require extensive further evaluation and even then they are
survivors of the atomic bombings by the Radiation Effects
probably multifactorial. In the meantime, an important
Research Foundation showed that those who undertook
theme emerging from the data is that a simple balanced
regular exercise and had a higher intake of fruit and
approach to lifestyle is safer than a faddy supplement-
vegetables had a significantly lower risk of cancer, despite
taking culture, as over-consumption of dietary supplements
can be unsafe or counterproductive. Ideally, future trialdesigns should include bespoke patient analysis to identifythose individuals with subclinical deficiencies in trace
elements and vitamins, which may lead to an increasedrisk or progression of cancer, especially under circum-
A number of methodological limitations confound the
stances of high carcinogen exposure. The levels and type of
interpretation of the benefits of exercise and diet after
dietary supplement for each individual will also probably
a diagnosis of cancer from other risks such as smoking, body
differ considerably, depending on the patient’s dietary
LIFESTYLE DURING AND AFTER CANCER TREATMENT
history and genetic susceptibility . As vitamin, mineral
How this advice should be formally introduced into
and essential fatty acid levels have not always been found
clinical practice requires close work with clinicians,
to reflect the true status of individual requirements
patients and advocacy groups. A straightforward first step
more complex tests may be required in addition to detailed
is to include lifestyle advice sheets in patient information
dietary questionnaires. These may include an analysis of
packs after their diagnosis, supported with well-written
a patient’s genetic signature measurement of serum
leaflets. This policy is already adopted by our and a number
metabolites that accumulate in vitamin deficiencies
of UK oncology units. Nurses could be trained to direct
serum lipid peroxide levels as an indicator of oxidative free
patients towards the myriad of council or independent
radical damage , or markers relating to the function
exercise activities available locally and with the Internet,
of the primary defence enzymes, catalase, glutathione
accessible information is even more readily available.
Cancernet.co.uk, for example, is able to search for a range
In the meantime, a logical, albeit pragmatic, approach is
of activities by postcode, ranging from ballroom, line and
summarised in This approach is based on the
salsa dance lessons, aerobics, yoga and fitness classes, local
evidence reviewed in this article, some of which is
walking, swimming and cycling groups through to gyms,
represented in . It essentially advises adequate
sport centres, tennis and badminton courts, pilates and
amounts of fresh fruits, brightly coloured berries, raw and
personal trainers; information on times, contact numbers
lightly cooked leafy and cruciferous vegetables, grains,
and locations is provided. Even if patients do not have
legumes, oily fish, nuts, dark green salads, tomatoes, and
access to the Internet, information on these local activities
soy products. This is complemented with advice to avoid
could be printed out as necessary during the patient’s
excessive unregulated over the counter supplementation,
particularly calcium and zinc at high doses, saturated fat,
A more comprehensive, but expensive, strategy is to
grilled meats, and other foods with high carcinogen
introduce structured lifestyle clinics facilitated by trained
content. Advice on increasing exercise among cancer
physiotherapists and nutritionists, the feasibility and cost-
effectiveness of which are currently under investigation in
Table 3 e Tips to encourage increased exercise activities in cancer patients
Exercise should not just be a passing fad, but be incorporated into our daily lives for the rest of our lives. During the day we have several choices, which require more or less levels of exertion. Try to take the moreactive option, such as walking instead of using the car for short journeys or getting off the bus or tube onestop earlier.
If you like exercising at home, it is worth having a semi-formal programme to follow. There are many usefulgadgets available to make it more fun (exercise bikes, treadmills, rowing machines, etc). Alternatively, followan exercise video d there are many good ones available. When watching television, try to get up and walkaround for a few minutes at every break.
Use the stairs instead of the lift. If possible take a walk at lunchtime. Try desk exercises d you may look odd,but they can keep you alert, especially when you get tired or sleepy. Do not worry about the comments d peoplewill secretly admire your enthusiasm.
There is an alternative to the pub or the television. Exercise can and should be sociable and enjoyable d findsomething that is fun, otherwise you will give it up very quickly.
In addition to integrating walking into our daily routine, social walking groups are available in many areas and area good way to meet new people, view interesting scenery and exercise to a variety ofability levels. Golf is a good encouragement to walk and clubs are available throughout Britain for all levels.
Cycling socially with family or part of a daily commute, even if only once or twice a week, can be fun andeven save money. Consider buying a bike with a basket for the shopping.
Joining a gym is always a good start. Paying money every month is a good incentive to use it. Even if you areoverweight or unfit, do not worry, as so are most other people and nobody of worth will criticise your efforts.
There are numerous enjoyable ways to exercise in groups at a variety of levels. Your local sports centrewill also have many activities from five-aside football, squash, badminton, volleyball, netball, and numerousexercise aerobics classes.
Many pools offer classes to learn to swim; they often offer single sex or disabled classes.
There are numerous dance classes available in most towns, from traditional ballroom and line dancing to rockand roll or salsa.
is able to search for a range of activities by postcode, providing times, contact numbers and locations.
our unit. The rationale for these clinics is that individu-
11 Thomas R, Blades M, Williams M, Godward S. Dietary advice
alised lifestyle counselling will probably elicit a response,
combined with a salicylate, mineral and vitamin supplement
especially as fundamental changes in the patient’s aspira-
(CV247) has some tumour static properties: a phase II study.
tions and abilities will probably have occurred after their
12 Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes
diagnosis and treatment. The cancer itself, surgery, or
may affect the progression of prostate cancer. J Urol 2005;
anticancer therapies may have caused physical disability,
fatigue, weight gain and reduced esteem in body image.
13 Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study
The baselines or benchmarks patients adopt when evaluat-
of pomegranate juice for men with rising PSA following surgery
ing their health status, including the activities they feel
or RXT for prostate cancer. Clin Cancer Res 2006;12(13):
they can and cannot participate in, are currently under
investigation at our clinic. The theory of health baseline
14 Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction
comparisons may influence a patient’s adjustment to
and over-expression of cyclooxygenase-2 in human prostate
cancer and lifestyle choices after a cancer diagnosis. If this
cancer: implications for prevention and treatment. Int J Urol
is the case, there will be scope for the development of
15 Baron JA, Cole BF, Sandler RS, et al. A randomised trial of
more effective, diverse and bespoke lifestyle interventions
aspirin to prevent colorectal adenomas. N Engl J Med 2003;
for cancer patients at diagnosis, during treatment, and on
16 Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal anti-
inflammatory drugs and breast cancer. Epidemiology 1996;7:203
Acknowledgement. The authors would like to extend their
17 Sandler RS, Halabi S, Baron JA, et al. A randomised trial of
gratitude to the editorial panel of Cancernet.co.uk for their
aspirin to prevent colorectal adenomas in patients with
provision of lifestyle guidance and information.
previous colorectal cancer. N Engl J Med 2003;348(10):883e890.
Author for correspondence: Professor R. Thomas, Cranfield
18 Blacklock CJ, Lawrence JR, Wiles D, et al. Salicylic acid in the
University, Bedford and Addenbrooke’s Hospital, c/o The Primrose
serum of subjects not taking aspirin. Comparison of salicylic
Unit, Bedford Hospital, Bedford MK42 9DJ, UK. Tel: þ44-01223-216-
acid concentrations in the serum of vegetarians, non-vegetar-
ians, and patients taking low dose aspirin. J Clin Pathol 2001;54:553e555.
Received 24 January 2007; received in revised form 9 May 2007;
20 Kroenke CH, Fung TT, Hu FB, et al. Dietary patterns and
survival after breast cancer diagnosis. J Clin Oncol 2005;23(36):9295e9303.
21 Iop A, Manfredi AM, Bonura S. Fatigue in cancer patients
receiving chemotherapy: an analysis of published studies. Ann
1 Shimizu H, Ross RK, Bernstein L, et al. Cancers of the prostate
and breast among Japanese and white immigrants in Los
22 Dimeo FC, Stieglitz RD, Novelli-Fischer U, et al. Effects
Angeles County. Br J Cancer 1991;63:963e999.
of physical exercise on the fatigue and psychological
2 Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate
status of cancer patients during therapy. Cancer 1999;85:
cancer development and progression. J Clin Oncol 2005;
23 Schwartz AL, Mori M, Gao R, et al. Exercise reduces daily
3 Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate
fatigue in patients with breast cancer receiving chemotherapy.
cancer: a review. Prostate Cancer Prostate Dis 2005;8:304e310.
Med Sci Sports Exerc 2001;33:718e723.
4 Wilkinson S, Chodak GW. Critical review of complementary
24 Galster H, et al. Activation of coagulation and thrombotic risk
therapies for prostate cancer. J Clin Oncol 2003;21(11):
for different groups. Thromb Res 2000;100:381e388.
25 Knols R, Aaronson NK, Uebelhart D, et al. Physical exercise in
5 Hall N. Survival in colorectal cancer: impact of body mass and
cancer patients during and after medical treatment: a systemic
review of randomised and controlled clinical trials. J Clin
6 Haydon AM, Macinnis RJ, English DR, et al. The effect of
physical activity and body size on survival after diagnosis with
26 Winningham M, MacVicar MG, Bondoc M, et al. Effect of
colorectal cancer. Gut 2006;55:62e67.
aerobic exercise on body weight and composition in patients
7 Quadrilatero J, Hoffman-Goetz L. Physical activity and colon
with breast cancer on adjuvant chemotherapy. Oncol Nurs
cancer. A systematic review of potential mechanisms. J Sports
27 MacVicar M, Winningham M, Nickel J. Effects of aerobic
8 Friedenreich CM, Orenstein MR. Physical activity and cancer
interval training on cancer patients’ functional capacity. Nurse
prevention: etiologic evidence and biological mechanisms.
J Nutr 2002;132(Suppl 11):3456e3464.
28 Kadan-Lottick NS, Vanderwerker LC, Block SD, et al. Psychi-
9 Thomas R, Daly M, Perryman J. Forewarned is forearmed e
atric disorders and mental health service use in patients with
randomised evaluation of a preparatory information film for
advanced cancer. Cancer 2005;104(12):2872e2881.
cancer patients. Eur J Cancer 2000;36(2):52e53.
29 Mock V, Dow KH, Meares C, et al. Effects of exercise on
10 Rorth M, Andersen C, Quist M, et al. Health benefits of a
fatigue, physical functioning, and emotional distress during
radiation therapy for breast cancer. Oncol Nurs Forum 1997;
undergoing chemotherapy. J Clin Oncol 2006;8010(Suppl.):731.
LIFESTYLE DURING AND AFTER CANCER TREATMENT
30 Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life
undergo intracellular metabolism to retinol. J Nutr 2000;130:
outcomes of exercise during cancer treatment. Cancer Pract
50 Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and
31 Courneya KS, Mackey JR, Bell GJ, et al. Randomized controlled
supplementation with alpha-tocopherol and beta carotene:
trial of exercise training in postmenopausal breast cancer
incidence and mortality in a controlled trial. J Natl Cancer Inst
survivors: cardiopulmonary and quality of life outcomes. J Clin
51 Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for
32 McKenzie D, Kalda A. Effect of upper extremity exercise on
lung cancer and for intervention effects in CARET, the beta-
secondary lymphedema in breast cancer patients: a pilot
carotene in retinol efficacy trial. J Natl Cancer Inst 1996;88:
study. J Clin Oncol 2003;21:463e466.
33 Pinto BM, Clark MM, Maruyama NC, et al. Psychological
52 Svilaas A, Sakhi AK, Andersen LF, et al. Intake of antioxidants
and fitness changes associated with exercise participation
in coffee, wine and vegetables are correlated with plasma
among women with breast cancer. Psychooncology 2003;12:
carotenoids in humans. J Nutr 2004;134:562e567.
53 Schoonen WM, Salinas CA, Kiemeney LALM, et al. Alcohol
34 Holmes MD, Stampfer MJ, Colditz GA, et al. Dietary factors and
consumption and the risk of prostate cancer in middle-aged
the survival of women with breast cancer. Cancer 1999;85(5):
54 Food and Drug Administration. Carcinogens and antioxidants,
35 Rohan TE, Hiller JE, McMichael AJ. Dietary factors and survival
from breast cancer. Nutr Cancer 1993;20:167e177.
55 Marklund SL, Westman NG, Lundgren E, et al. Copper- and
36 Dignam JJ, et al. Effect of body mass index on outcome in
zinc-containing superoxide dismutase, manganese-containing
patients with dukes B and C colon cancer: an analysis of NSABP
superoxide dismutase, catalase, and glutathione peroxidase in
trials. J Clin Oncol 2006;3533:254s.
normal and neoplastic human cell lines and normal human
37 Gross M, et al. Obesity, ethnicity and surgical outcome for
tissues. Cancer Res 1982;42(5):1955e1961.
clinically localized prostate cancer. J Clin Oncol 2006;5(9615
56 Coombs GF. Status of selenium in prostate cancer prevention.
38 Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. The impact
57 Jackson MJ, et al. Are there functional consequences of
of physical activity on patients with stage III colon cancer:
a reduction in selenium intake in UK subjects? Proc Nutr Soc
findings from Intergroup trial CALGB 89803. Proc Am Soc Clin
58 DiSilvestro RA. Copper activation of superoxide dismutase
in rat erythrocytes. Arch Biochem Biophys 1989;274(1):
menopausal women with primary breast cancer. J Clin Oncol
59 Levieux A. Immunoquantitation of rat erythrocyte superoxide
40 Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term
dismutase: its use in copper deficiency. Free Radic Biol Med
smoking cessation in head and neck cancer patients. Cancer
Epidemiol Biomarkers Prev 1993;2:261e270.
60 Merli A, Rossi GL, Djinoviccarugo K, et al. Evidence for
41 Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and
breaking of the active site dimetal cluster in Cu,Co superoxide
predictors of continued tobacco use after treatment of
dismutase upon copper reduction: a polarized absorption
patients with head and neck cancer. Cancer 1995;75(2):
spectra study. Biochem Biophys Res Commun 1995;25:
42 Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation
61 Westman NG, Marklund SL. Copper- and zinc-containing
after successful treatment of small-cell lung cancer is
superoxide dismutase and manganese-containing superoxide
dismutase in human tissues and human malignant tumours.
cancers. Ann Intern Med 1993;119:383e390.
43 Stevens MH, Gardner JW, Parkin JL, et al. Head and neck
62 Liang JY, Liu YY, Zou J, et al. Inhibitory effect of zinc on
cancer survival and life-style change. Arch Otolaryngol Head
human prostatic carcinoma cell growth. Prostate 1999;40:
44 Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative
63 Leitzmann MF, Stampfer MJ, Wu K, et al. Zinc supplement use
DNA damage in prostate cancer patients consuming tomato
and risk of prostate cancer. J Natl Cancer Inst 2003;95:
sauce-based entrees as a whole-food intervention. J Natl
64 Clark LC, et al. Decreased incidence of prostate cancer with
45 Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of
selenium supplementation: results of a double-blind cancer
tomato products, lycopene, and prostate cancer risk. J Natl
prevention trial. Br J Urol 1998;81:730e734.
65 Costello AJ. A randomised, controlled chemoprevention
46 Giovannucci EL, et al. A prospective study of physical activity
trial of selenium in familial prostate cancer: rationale,
and incident of fatal prostate cancer. Arch Intern Med 2005;
recruitment, and design issues. Urology 2001;57(Suppl 1):
47 Stivala LA, Savio M, Quarta S, et al. The antiproliferative
66 Millier M. Enrollment begins for largest-ever prostate cancer
effect of beta-carotene requires p21waf1/cip1 in normal
prevention trial. J Natl Cancer Inst 2001;93:1132.
human fibroblasts. J Biochem 2000;267:2290e2296.
67 Rodriguez C, Jacobs EJ, Mondul AM, et al. Vitamin E
48 Kucuk O, Sarkar FH, Djuric Z, et al. Effects of lycopene
supplements and the risk of prostate cancer. Cancer Epidemiol
supplementation in patients with localized prostate cancer.
68 Campbell MJ, Koeffler HP, et al. Toward therapeutic
49 Williams AW, Boileau TWM, Zhou JR, et al. Beta-carotene
intervention of cancer by vitamin D compounds. J Natl Cancer
modulates human prostate cancer cell growth and may
69 Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase
90 Terry P, Lichtenstein P, Feychting M, et al. Fatty fish
in genital skin fibroblasts and prostate tissue by dietary lignans
consumption and risk of prostate cancer. Lancet 2001;357:
and isoflavonoids. J Endocrinol 1995;147:295e302.
70 Hsieh T, Wu JM. Induction of apoptosis and altered nuclear/
91 Norrish AE, Skeaff CM, Arribas GL, et al. Prostate cancer risk
cytoplasmic distribution of the androgen receptor and
and the consumption of fish oils: a dietary biomarker-based
prostate-specific antigen by 1 alpha, 25-dihydroxyvitamin D3
caseecontrol study. Br J Cancer 1999;81:1238e1242.
in androgen-responsive LNCaP cells. Biochem Biophys Res
92 Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty
acids and the risks of cancers of the breast and prostate and of
71 Slawin K, Kadmon D, Park SH, et al. Dietary fenretinide
other hormone-related cancers: a review of the epidemiologic
decreases the tumour incidence of ras induced carcinomas in
evidence. Am J Clin Nutr 2003;77:532e543.
the mouse reconstitution model system. Cancer Res 1993;53:
93 Chaudry AA, Wahle KW, McClinton S, et al. Arachidonic acid
metabolism in benign and malignant prostatic tissue in vitro:
72 Paganini-Hill A, Chao A, Ross RK, et al. Vitamin A, beta
effects of fatty acids and cyclooxygenase inhibitors. Int J
carotene and the risk of prostate cancer. J Natl Cancer Inst
94 Hsu AL, Ching TT, Wang DS, et al. The cyclooxygenases-2
73 Lee CY. Phytochemicals and apples. Lancet 2002;359(12):9301.
inhibitor celecoxib induces apoptosis by blocking Akt activa-
74 Fraga CU. Ascorbic acid protects against endogenous oxidative
tion in human prostate cancer cells independently of Bcl-2.
DNA damage in human sperm. Proc Natl Acad Sci USA 1991;8:
95 Dieppe P, Ebrahim S, Juni P. Lessons from the withdrawal from
75 Peehl DM, Skowronski RJ, Leung GK, et al. Antiproliferative
rofecoxib. Br Med J 2004;329:867e868.
effects of 1, 25-dihydroxyvitamin D3 on primary cultures of
96 Egan KM, Stampfer MJ, Giovannucci E, et al. Prospective study
human prostatic cells. Cancer Res 1994;54:805e810.
of regular aspirin use and the risk of breast cancer. J Natl
76 Schwartz GG, Whitlatch LW, Chen TC, et al. Human prostate
cancer cells: inhibition of proliferation by vitamin D analogs.
97 Fuchs C, Meyerhardt JA, Heseltine DL, et al. Influence of
regular aspirin use on survival for patients with stage III colon
77 Blutt SE, McDonnell TJ, Polek TC, et al. Calcitriol-induced
cancer: findings from intergroup trial CALGB 89803. Am Soc
apoptosis in LNCaP cells is blocked by overexpression of bcl-2.
98 Schreinemachers DM, Everson RB. Aspirin use and lung, colon
78 Zhao XY, Ly LH, Peehl DM, et al. Induction of androgen
and breast cancer incidence in a prospective study. Epidemi-
receptor by 1 alpha, 25-dihydroxyvitaminD3 and 9-cis retinoic
acid in LNCaP human prostate cancer cells. Endocrinology
99 Mahmud S, Franco E, Aprikian A. Prostate cancer and use of
nonsteroidal anti-inflammatory drugs: systematic review and
79 Chan JM, Stampfer MJ, Ma J, et al. Supplemental vitamin E
meta-analysis. Br J Cancer 2003;90:93e99.
intake and prostate cancer risk in a large cohort of men in the
100 Hippisley-Cox J, Coupland C. Risk of myocardial infarction
United States. Cancer Epidemiol Biomarkers Prev 1999;8:
in patients taking cyclo-oxygenase-2 inhibitors or conven-
tional non-steroidal anti-inflammatory drugs: population
80 Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary
based nested caseecontrol analysis. Br Med J 2005;330:
prevention of cardiovascular disease and cancer. The Women’s
Health Study: a randomised controlled trial. J Am Med Assoc
101 Westerlind KC. Physical activity and cancer prevention
mechanisms. Med Sci Sports Exerc 2003;35:1834e1840.
81 Holmes MD, Chen WY, Feskanich D, et al. Physical activity and
102 Harvei S, Bjerve KS, Tretli S, et al. Prediagnostic level of fatty
survival after breast cancer diagnosis. J Am Med Assoc 2005;
acids in serum phospholipids: omega-3 and omega-6 fatty acids
and the risk of prostate cancer. Int J Cancer 1997;71:545e551.
82 Amling C, Riffenburgh RH, Sun L, et al. Pathologic variables
103 Kristal AR, Cohen JH, Qu P, et al. Associations of energy, fat,
and recurrence rates as related to obesity and race in men
calcium and vitamin D with prostate cancer risk. Cancer
with prostate cancer undergoing radical prostatectomy. J Clin
Epidemiol Biomarkers Prev 2002;11:719e725.
104 Giovannucci E. Insulin, insulin-like growth factors and colon
83 Chlebowski R, Aiello E, McTiernan A. Weight loss in breast
cancer: a review of the evidence. J Nutr 2001;131(Suppl 11):
cancer patient management. J Clin Oncol 2002;20:1128e1143.
84 Wu A, Pike M, Stram D. Dietary fat intake, serum estrogen
105 Kaaks R, Toniolo T, Akhmedkhanov A, et al. Serum C-peptide,
levels, and the risk of breast cancer. J Natl Cancer Inst 1999;
insulin-like growth factor (IGF)-I, IGF-binding proteins, and
colorectal cancer risk in women. J Natl Cancer Inst 2000;92:
85 Adlercreutz H, Fotsis T, Bannwart C. Urinary estrogen profile
determination in young Finnish vegetarian and omnivorous
106 Giovannucci E, Pollak MN, Platz EA, et al. A prospective study
women. J Steroid Biochem 1986;24:289e295.
of plasma insulin-like growth factor-1 and binding protein-3
86 Rose DP. Dietary fibre, phytoestrogens and breast cancer.
and risk of colorectal neoplasia in women. Cancer Epidemiol
87 Keyomarsi K. Synchronization of tumour cells by Lovastatin.
107 Ma J, Giovannucci E, Pollak M, et al. A prospective study of
plasma C-peptide and colorectal cancer risk in men. J Natl
88 Graaf MR, Beiderbeck AB, Egberts ACG, et al. The risk of
cancer in users of statin. J Clin Oncol 2004;22:2366e2394.
108 Ma J, Pollak MN, Giovannucci E, et al. Prospective study of
89 Augustsson K, Michaud DS, Rimm EB, et al. A prospective study
colorectal cancer risk in men and plasma levels of insulin-
of intake of fish and marine fatty acids and prostate cancer.
like growth factor (IGF)-I and IGF binding protein-3. J Natl
Cancer Epidemiol Biomarkers Prev 2003;12:64e67.
LIFESTYLE DURING AND AFTER CANCER TREATMENT
109 Nomura AM, Stemmermann GN, Lee J, et al. Serum insulin-like
growth factor I and subsequent risk of colorectal cancer among
vascular endothelial growth factor by insulin-like growth
Japanese-American men. Am J Epidemiol 2003;158:424e431.
factor 1 in colorectal carcinoma. J Biol Chem 1996;271:
110 Palmqvist R, Hallmans G, Rinaldi S, et al. Plasma insulin-like
growth factor 1, insulin-like growth factor binding protein 3,
117 Giles GG, English DR. The Melbourne Collaborative Cohort
and risk of colorectal cancer: a prospective study in northern
Study. IARC Sci Publ 2002;156:69e70.
118 Land CE. Studies of cancer and radiation dose among atomic
111 Probst-Henson NM, Yuan JM, Stanczyk FZ, et al. IGF-1, IGF-2
bomb survivors: the example of breast cancer. J Am Med Assoc
and IGFBP-3 in prediagnostic serum: association with co-
lorectal cancer in a cohort of Chinese men in Shanghai. Br J
119 Li H. Manganese superoxide dimutase polymorphism, prediag-
nostic antioxidant status and risk of clinical significant
112 Baxter RC, Turtle JR. Regulation of hepatic growth hormone
prostate cancer. Cancer Res 2005;65:2498e2504.
receptors by insulin. Biochem Biophys Res Commun 1978;84:
120 Joosten E, van den Berg A, Riezler R, et al. Metabolic
evidence that deficiencies of vitamin B12, folate, and vitamin
113 Suikkari AM, Koivisto VA, Rutanen EM, et al. Insulin regulates
B6 occur commonly in older people. Am J Clin Nutr 1992;58:
the serum levels of low molecular weight insulin-like growth
factor-binding protein. J Clin Endocrinol Metab 1988;66:
121 Slater TF, Cheeseman KH, Davies MJ, et al. Free radical
mechanisms in relation to tissue injury. Proc Nutr Soc 1987;1:
114 Yu H, Rohan T. Role of the insulin-like growth factor family in
cancer development and progression. J Natl Cancer Inst 2000;
122 One To One Health Exercise and Nutrition,
115 Freier S, Weiss O, Eran M, et al. Expression of the insulin-like
123 Davies NJ, Kinman G. Health baseline comparison theory:
growth factors and their receptors in adenocarcinoma of the
Adjustment to rheumatoid arthritis. Health Psychol Update
El Trastorno por Déficit de Atención (ADD) y el Trastorno por Déficit de Atención con Hiperactividad: Nutrición, Causas, Prevención y Terapias. ( Tomado de Ronald Roth, 2010, Se adjunta original en ingles. ) El Trastorno de Déficit de Atención (ADD) y Déficit de Atención e Hiperactividad (ADHD) se han convertido en una moda médica de proporciones sin precedentes. Hasta el 20%